This paper uses data from seven countries (Cambodia, India, The Gambia, Ghana, Laos, Rwanda, and USA) to explore factors such as the blood sampling site (capillary vs venous), the equipment (HemoCue vs automated hematology analyzer) and the model of the HemoCue device (201+ vs 301) that may impact hemoglobin measurements in capillary and venous blood.